Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a 6-Session CBT approach outperform traditional talk therapy for PTSD?

NCT ID NCT07710573

Symptom relief Sponsor: Community Stress Prevention Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study tests a short, focused cognitive-behavioral therapy (CBT) called Brief SEE FAR CBT against standard dynamic psychotherapy for adults with posttraumatic stress disorder (PTSD). Participants in the CBT group receive 6 weekly sessions targeting intrusive PTSD symptoms, then continue to a full 12-session protocol. The control group receives standard dynamic psychotherapy. Researchers track changes in PTSD, anxiety, depression, and other outcomes at several points over 3 months to see if the brief approach works as well or better.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Brief SEE FAR CBT (cognitive-behavioral therapy) and dynamic psychotherapy
What this could lead to
If successful, this brief CBT approach could offer a faster, more focused treatment option for PTSD, reducing symptoms in fewer sessions.
What could go wrong
This is a small, early-stage study with only 60 participants, so results may not apply to everyone. The brief intervention may not be as effective as longer therapies for some people.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria Participants must meet all of the following criteria: * Age 18 years or older * PTSD symptoms, defined as a PCL-5 score of 30-60 * Hebrew-speaking * Able to provide informed consent * Willing and able to participate in the assigned psychological intervention and complete study questionnaires at baseline, after 6 sessions, after 12 sessions, and at 3-month follow-up Exclusion Criteria Participants will be excluded if they meet any of the following criteria: * Pregnancy at the time of enrollment, due to the potential influence of pregnancy and childbirth during the treatment or follow-up period on psychological outcomes * Currently receiving psychotherapy of any type that began less than 3 months prior to enrollment * Initiation of psychiatric medication less than 3 months prior to enrollment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-traumatic stress disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post-traumatic stress disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Center for Psychological Services Sha'ar Hanegev

    RECRUITING

    Sha'ar Hanegev, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.